Prescient Therapeutics (ASX:PTX) shares outperform on latest quarterly report
Prescient Therapeutics (PTX) outperformed its health sector peers on the ASX today after releasing its...
Prescient Therapeutics (PTX) outperformed its health sector peers on the ASX today after releasing its...
Two of Prescient Therapeutics' (PTX) assets have been handpicked for a COVID-19 antiviral testing program....
Anti-cancer biotech company Prescient Therapeutics (PTX) has received two key licences to build a new...
Anti-cancer biotech company Prescient Therapeutics (PTX) has received two key licences to build a new...
Prescient Therapeutics (PTX) shares rose 60 per cent this morning after expanding its Phase 1b...
Prescient Therapeutics has entered a collaboration with Carina Biotech to develop new targeted cell therapies...
To stay up to date with Prescient Therapeutics news and events, please register your details.